Certain Mouth Bacteria Linked to Pulmonary Fibrosis Survival
Surprisingly, one bacterial species tended to dominate in certain patients with IPF who were not treated with antibiotics—and those patients were more likely to survive.
Surprisingly, one bacterial species tended to dominate in certain patients with IPF who were not treated with antibiotics—and those patients were more likely to survive.
Two studies presented at CHEST 2023 validated the effectiveness of the Envisia Genomic Classifier in improving the detection of interstitial lung disease.
Stem cell cloning experts are reporting their findings of variant cells in the lungs of patients with idiopathic pulmonary fibrosis, which likely represent key targets in any future therapy for the condition.
MUC5AC, an airway protein, plays an important (and overlooked) role in the body’s mucociliary clearance system, according to research published in Science Advances.
Read MoreZinc, a common mineral, may reverse lung damage and improve survival for patients with idiopathic pulmonary fibrosis (IPF), according to researchers from the Women’s Guild Lung Institute at Cedars-Sinai.
Read MoreImportant research results from five studies examining access to care and outcomes for patients living with pulmonary fibrosis and interstitial lung disease (ILD) are being presented at ATS 2022.
Read MoreUpdated clinical practice guidelines from ATS/ERS cover idiopathic pulmonary fibrosis and address progressive pulmonary fibrosis in patients with interstitial lung diseases other than IPF.
Read MoreA study in the journal Respiration showed that patients with idiopathic pulmonary fibrosis who were treated with nintedanib saw more positive outcomes.
Read MoreBoehringer Ingelheim’s BI 1015550 is a PDE4B inhibitor with the potential to address both pulmonary fibrosis and inflammation associated with progressive fibrosing interstitial lung diseases.
Read MoreRepeated injury to the epithelial tissue of the airways causes “biological aging” of the stem cells located there, which plays a significant role in the development of chronic lung disease.
Read MoreTo drive awareness of interstitial lung disease, nine organizations are collaborating to present the first-ever ILD Day on September 15.
Read MoreBroadway actor Julie Halston recently won a Tony Award in recognition of her pulmonary fibrosis advocacy work.
Read MoreResearch shows it may be possible to reverse fibrosis and promote tissue repair through treatment with microgel-coated mesenchymal stromal cells.
Read MorePatients with idiopathic pulmonary fibrosis (IPF) have worse outcomes if they live in poor neighborhoods.
Read MoreThe removal of race correction in PFT results led to an increase in the percentage of patients with any pulmonary defect from 59.5% to 81.7%, a significant difference of 20.8%.
Read More